Table 1.
Embryonic versus adult versus induced pluripotent stem cells for cell-based therapy.
| Cell type | Advantages | Disadvantages |
|---|---|---|
| Embryonic stem cell | (i) Pluripotent (can form all lineages of the body: ectoderm, mesoderm, endoderm) (ii) Grown relatively easily |
(i) Likely to be rejected (if donor is allogeneic, unmatched) (ii) Harbors disease-causing genes of donor Ethical problems (iii) Chromosomal errors (aneuploidy), mitochondrion DNA defects, karyotype instability [40], and risk of teratoma formation following transplantation [10] |
|
| ||
| Adult stem cell | (i) Multipotent (can form multiple cell types of 1 lineage, e.g., retinal progenitor cell) (ii) Not rejected if transplanted into donor |
(i) Relatively hard to harvest (ii) Harbors disease-causing genes of donor |
|
| ||
| Induced pluripotent stem cell | (i) Pluripotent (ii) Grown relatively easily (iii) Probably not rejected if transplanted into donor |
(i) May retain epigenetic features of cell type of origin (ii) Harbors disease-causing genes of donor (iii) Oncogenic potential of cells as a consequence of genetic manipulation [41] |